{"title":"预测急性缺血性脑卒中合并心房颤动患者出血转化风险的Nomogram","authors":"Jingjuan Chen, Mingyi Bao, Chengguo Zhang, Dong Pan, Yanting Chen, Yongteng Xu, Feng Zhou, Yamei Tang","doi":"10.1111/cns.70402","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Hemorrhagic transformation (HT) is a critical complication in acute ischemic stroke (AIS) patients with atrial fibrillation (AF) awaiting anticoagulation reinitiation. No reliable predictive model exists for assessing HT risk for these patients. Clinical decisions typically rely on NIHSS score and infarct size; however, other relevant risk factors remain insufficiently explored. This study aimed to develop and validate a predictive model for assessing the risk of HT in AIS patients with AF from stroke onset to anticoagulation therapy reinitiation.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This retrospective study included AIS patients with AF from two comprehensive medical centers in China. The primary outcome was HT postinfarction confirmed with CT/MRI before anticoagulation reinitiation. Significant predictors were identified via LASSO regression in the training set, followed by multivariable logistic regression for developing a predictive model and generating the nomogram. Model performance was validated in a separate external cohort.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In the training cohort (<i>n</i> = 629), 174 patients (27.7%) developed HT. LASSO logistic regression revealed that infarct size, NIHSS score, diabetes mellitus, reperfusion therapy, left ventricular ejection fraction, and prehospital antihypertensive treatment were significant HT predictors. In the external validation cohort (<i>n</i> = 236), 61 patients (25.8%) developed HT. The nomogram exhibited strong predictive performance, with AUCs of 0.720 in the training set and 0.747 in the validation set.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The proposed nomogram offers a practical tool for predicting HT risk in AIS patients with AF before anticoagulation reinitiation, potentially supporting informed clinical decision-making, though further validation is required.</p>\n </section>\n </div>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"31 4","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.70402","citationCount":"0","resultStr":"{\"title\":\"Nomogram for Predicting Hemorrhagic Transformation Risk in Acute Ischemic Stroke Patients With Atrial Fibrillation\",\"authors\":\"Jingjuan Chen, Mingyi Bao, Chengguo Zhang, Dong Pan, Yanting Chen, Yongteng Xu, Feng Zhou, Yamei Tang\",\"doi\":\"10.1111/cns.70402\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Hemorrhagic transformation (HT) is a critical complication in acute ischemic stroke (AIS) patients with atrial fibrillation (AF) awaiting anticoagulation reinitiation. No reliable predictive model exists for assessing HT risk for these patients. Clinical decisions typically rely on NIHSS score and infarct size; however, other relevant risk factors remain insufficiently explored. This study aimed to develop and validate a predictive model for assessing the risk of HT in AIS patients with AF from stroke onset to anticoagulation therapy reinitiation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>This retrospective study included AIS patients with AF from two comprehensive medical centers in China. The primary outcome was HT postinfarction confirmed with CT/MRI before anticoagulation reinitiation. Significant predictors were identified via LASSO regression in the training set, followed by multivariable logistic regression for developing a predictive model and generating the nomogram. Model performance was validated in a separate external cohort.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>In the training cohort (<i>n</i> = 629), 174 patients (27.7%) developed HT. LASSO logistic regression revealed that infarct size, NIHSS score, diabetes mellitus, reperfusion therapy, left ventricular ejection fraction, and prehospital antihypertensive treatment were significant HT predictors. In the external validation cohort (<i>n</i> = 236), 61 patients (25.8%) developed HT. The nomogram exhibited strong predictive performance, with AUCs of 0.720 in the training set and 0.747 in the validation set.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The proposed nomogram offers a practical tool for predicting HT risk in AIS patients with AF before anticoagulation reinitiation, potentially supporting informed clinical decision-making, though further validation is required.</p>\\n </section>\\n </div>\",\"PeriodicalId\":154,\"journal\":{\"name\":\"CNS Neuroscience & Therapeutics\",\"volume\":\"31 4\",\"pages\":\"\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-04-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.70402\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS Neuroscience & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cns.70402\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.70402","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Nomogram for Predicting Hemorrhagic Transformation Risk in Acute Ischemic Stroke Patients With Atrial Fibrillation
Background
Hemorrhagic transformation (HT) is a critical complication in acute ischemic stroke (AIS) patients with atrial fibrillation (AF) awaiting anticoagulation reinitiation. No reliable predictive model exists for assessing HT risk for these patients. Clinical decisions typically rely on NIHSS score and infarct size; however, other relevant risk factors remain insufficiently explored. This study aimed to develop and validate a predictive model for assessing the risk of HT in AIS patients with AF from stroke onset to anticoagulation therapy reinitiation.
Methods
This retrospective study included AIS patients with AF from two comprehensive medical centers in China. The primary outcome was HT postinfarction confirmed with CT/MRI before anticoagulation reinitiation. Significant predictors were identified via LASSO regression in the training set, followed by multivariable logistic regression for developing a predictive model and generating the nomogram. Model performance was validated in a separate external cohort.
Results
In the training cohort (n = 629), 174 patients (27.7%) developed HT. LASSO logistic regression revealed that infarct size, NIHSS score, diabetes mellitus, reperfusion therapy, left ventricular ejection fraction, and prehospital antihypertensive treatment were significant HT predictors. In the external validation cohort (n = 236), 61 patients (25.8%) developed HT. The nomogram exhibited strong predictive performance, with AUCs of 0.720 in the training set and 0.747 in the validation set.
Conclusions
The proposed nomogram offers a practical tool for predicting HT risk in AIS patients with AF before anticoagulation reinitiation, potentially supporting informed clinical decision-making, though further validation is required.
期刊介绍:
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.